DaVita stock trades at EUR 154.65 as Q2 EPS beats estimates
Published on 09/30/2026 at 10:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
DaVita stock (ISIN US23918K1088) was trading at EUR 154.65 at Lang & Schwarz on September 30, 2026 at 10:29 a.m. CEST, plus 0.14 percent versus the prior close of EUR 154.43. The latest quarterly figures showed diluted EPS of USD 4.02 against USD 3.88 consensus, while revenue reached USD 3.554 billion.
Q2 earnings beat expectations
According to StockTitan in its August 4, 2026 filing summary, DaVita reported USD 579.0 million in operating income and USD 490.1 million in operating cash flow for the quarter ended June 30, 2026. Operating margin improved to 16.30 percent from 14.10 percent in the prior quarter.
The revenue result also represented a 5.20 percent year-over-year increase, according to MarketBeat on September 26, 2026. The combination of higher revenue and a 4.02 EPS result gives the quarterly report a stronger earnings profile than the 3.88 consensus benchmark.
Guidance stays between USD 14.10 and USD 15.20
DaVita's adjusted diluted EPS guidance for fiscal 2026 remains USD 14.10-15.20, while adjusted operating income guidance is USD 2.15-2.25 billion, according to StockTitan. Free cash flow guidance is USD 1.0-1.25 billion, making cash generation a key checkpoint alongside treatment volume and cost control.
Analyst caution offsets earnings strength
MarketBeat reported on September 26, 2026 that Wall Street Zen cut DaVita from Buy to Hold. The average analyst price target was USD 233.43, while the consensus rating was Hold, creating a mixed signal after the quarterly earnings beat.
DaVita stock trades at EUR 154.65
DaVita stock was trading at EUR 154.65 at Lang & Schwarz on September 30, 2026 at 10:29 a.m. CEST, plus 0.14 percent versus the EUR 154.43 prior close. The company had a market capitalization of USD 11.2 billion and a 52-week range of USD 101.00 to USD 247.49 as of September 29, 2026.
DaVita stock facts
- Company: DaVita Inc.
- ISIN: US23918K1088
- Ticker: DVA
- Primary exchange: NYSE
- Price Lang & Schwarz (as of September 30, 2026, 10:29 a.m. CEST): EUR 154.65
- Change versus prior close: plus 0.14 percent
- Prior close Lang & Schwarz (September 29, 2026): EUR 154.43
- Market capitalization: USD 11.2 billion (as of September 29, 2026)
- 52-week range: USD 101.00-247.49 (as of September 29, 2026)
- Sector / Industry: Healthcare / Medical Care Facilities
